LeonaBio (LONA) Total Liabilities (2019 - 2026)

LeonaBio (LONA) has 8 years of Total Liabilities data on file, last reported at $22.3 million in Q1 2026.

• Quarterly Total Liabilities rose 260.46% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (up 260.46% YoY) and the FY2025 annual result came in at $64.4 million, up 361.77% from the prior year.
• Total Liabilities fell to $22.3 million in Q1 2026 per LONA's latest filing, from $64.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $64.4 million in Q4 2025 and bottomed at $3.2 million in Q3 2025.
• The 5-year median for Total Liabilities is $22.3 million (2026), against an average of $21.1 million.
• Peak annual rise in Total Liabilities reached 361.77% in 2025, while the deepest fall reached 88.67% in 2025.
• Tracing LONA's Total Liabilities over 5 years: stood at $23.0 million in 2022, then surged by 30.59% to $30.1 million in 2023, then tumbled by 53.63% to $13.9 million in 2024, then surged by 361.77% to $64.4 million in 2025, then sank by 65.37% to $22.3 million in 2026.
• Per Business Quant, the three latest LONA Total Liabilities figures stand at $22.3 million (Q1 2026), $64.4 million (Q4 2025), and $3.2 million (Q3 2025).

Peer Comparison